Objective Measures of Cochlear Implant Electrode Position and Function
1 other identifier
interventional
30
1 country
1
Brief Summary
Recruit adult patients eligible for cochlear Implant surgery. During routine surgery monitor electrode placement with new 'SCINSEV' technique and complete 'PECAPs' on patient to identify if any of the electrodes have misplaced. Follow up with patient after surgery for post operative appointment with same measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedFirst Posted
Study publicly available on registry
August 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedAugust 25, 2021
August 1, 2021
10 months
September 25, 2020
August 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of extra cochlear electrodes
Number of extra-cochlear electrodes obtained using our "SCINSEV" analysis correspond to the actual number of extra-cochlear electrodes observed during different stages of insertion.
12 months
Secondary Outcomes (1)
Pre and post op loudness comparison
12 months
Study Arms (1)
Standard of Care
OTHERInterventions
To measure PECAP and SCINSEVs. To find whether electrodes are outside of the cochlear or within dead regions within the cochlear.
Eligibility Criteria
You may qualify if:
- Participant is willing or able to consent to participation in the study
- Meets normal candidacy requirements for cochlear implantation
- At least 18 years of age at time of consent being given
- Patent cochlea as verified by CT or MRI scan
- No additional complex needs that would prevent study procedures being followed
- Agreement to participate in the study
You may not qualify if:
- Using medication in a manner that might affect hearing levels
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sophie McKennylead
- University of Cambridgecollaborator
Study Sites (1)
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 OQQ, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Daniele Borsetto
Addenbrookes Hospital, CUH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Researcher
Study Record Dates
First Submitted
September 25, 2020
First Posted
August 3, 2021
Study Start
December 1, 2020
Primary Completion
October 1, 2021
Study Completion
January 1, 2022
Last Updated
August 25, 2021
Record last verified: 2021-08